
Convoke, a San Francisco a pioneering technology company developing an artificial intelligence AI-powered operating system for the biopharmaceutical industry.
Convoke was funded $8.6 million led by Kleiner Perkins and Dimension Capital, with participation from ACME, Comma Capital, Liquid2, Not Boring Capital, Audacious, Lux Capital, and angel investors including Qasar Younis, Erik Torenberg, and other.
The investment will be used to accelerate the development and commercialization of their innovative platform, designed to streamline and optimize various aspects of drug discovery and development.
The biopharmaceutical sector faces significant challenges,
Continue reading..